Novo Nordisk, Wegovy
The European Medicines Agency’s (EMA) advisory committee the CHMP has adopted a positive opinion for a label update of Danish ...
U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...
Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...
A new study found that people taking Wegovy during the pandemic were 33 percent less likely to die of COVID-19.
A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...
For patients on a 12-month plan, Hims offers a semaglutide injection for $199 a month. Ozempic and Wegovy carry high list prices of $935.77 and $1,349.02, respectively, for a month’s supply, ...
People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...
A SELECT trial subanalysis showed that semaglutide works as well in people with CVD, overweight/obesity, and impaired kidney ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback